| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Zhong,Wei-Kai | Chairman | 49.17% | YungShin Global Holding Corporation |
| Li,Fang-Xin | Director | 49.17% | YungShin Global Holding Corporation |
| Lin,Meng-Bi | Director | 49.17% | YungShin Global Holding Corporation |
| Li,Fang-Yu | Director | 49.17% | YungShin Global Holding Corporation |
| Vacancy | Director | 0.00% | |
| Lin,Jun-Wei | Director | 0.00% | |
| Luo,Bao-Zhu | Independent Director | 0.00% | |
| Yang,Pan-Jiang | Independent Director | 0.00% | |
| Li,Shu-Hui | Independent Director | 0.00% | |
| Wang,Qi-Ming | Independent Director | 0.00% |
Change Company Name to VETNOSTRUM ANIMAL HEALTH CO., LTD.
2024/07/22
Change Person in Charge to Li,Fang-Yu
2023/10/23
Change Person in Charge to
2023/09/14
Change Company Name to YONGHONG INTERNATIONAL BIOTECHNOLOGY CO., LTD. (FORMER NAME: ZOETIS BIOTECHNOLOGY CO., LTD.)
2022/09/30
Change Capital to 2,100,000,000
2022/04/01
Change Person in Charge to Li,Fang-Yu
2018/09/10
Change Person in Charge to Zhong,Wei-Kai
2018/04/13
Change Company Name to VETNOSTRUM ANIMAL HEALTH CO., LTD.
2016/05/17
Change Person in Charge to Li,Ling-Jin
2016/05/17
Change Company Name to SHUO TENG BIOTECH CO., LTD.
2013/02/22
Change Capital to 550,000,000
2012/10/23
Change Company Name to HUI RUI ASIA CO., LTD.
2012/05/31
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 340,756 | 1,294,112 | 1,207,507 |
| Operating cost | 225,267 | 853,423 | 850,745 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 115,489 | 440,689 | 356,762 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 115,489 | 440,689 | 356,762 |
| Operating expenses | 73,183 | 269,956 | 245,220 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 42,306 | 170,733 | 111,542 |
| Non-operating income and expenses | 725 | -1,015 | 1,488 |
| Net profit (loss) before tax | 43,031 | 169,718 | 113,030 |
| Income tax expense (benefits) | 7,869 | 33,099 | 21,430 |
| Net profit (loss) of ongoing business for the current period | 35,162 | 136,619 | 91,600 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 35,162 | 136,619 | 91,600 |
| Other comprehensive profit (loss), net | - | -16 | -555 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 35,162 | 136,603 | 91,045 |
| Net profit (loss) attributable to owners of parent company | - | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 2 | 1 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | - | - | - |
| Net cash inflows (outflows) from investing activities | - | - | - |
| Net cash inflow (outflow) from financing activities | - | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
| Beginning balance of cash and cash equivalents | - | - | - |
| Ending balance of cash and cash equivalents | - | - | - |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 787,494 | 757,251 | 677,904 |
| Non-current asset | 699,497 | 681,093 | 701,687 |
| Total asset | 1,486,991 | 1,438,344 | 1,379,591 |
| Current liability | 300,510 | 288,684 | 310,324 |
| Non-current liability | 20,828 | 19,169 | 7,260 |
| Total liability | 321,338 | 307,853 | 317,584 |
| share capital | 663,390 | 663,390 | 662,890 |
| Equity - secruity token | - | - | - |
| capital reserve | 31,779 | 31,779 | 31,454 |
| retained earning | 470,484 | 435,322 | 367,663 |
| Other equity | - | - | 0 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | - | - | - |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 1,165,653 | 1,130,491 | 1,062,007 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 17 | 17 | 16 |
